Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Completed2

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%

recruiting250%

Recent Activity

2 active trials

Showing 4 of 4

recruitingnot_applicable

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor

NCT06993571

completednot_applicable

tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex

NCT07240272

recruitingnot_applicable

Efficacy of Triple-daily 15mA tACS on Adolescent NSSI

NCT06919432

completednot_applicable

Transcranial Alternating Current Stimulation (tACS) to Improve Motor Skill Acquisition in Stroke Patients

NCT05576129

Clinical Trials (4)

Showing 4 of 4 trials

NCT06993571Not Applicable

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor

Recruiting

NCT07240272Not Applicable

tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex

Completed

NCT06919432Not Applicable

Efficacy of Triple-daily 15mA tACS on Adolescent NSSI

Recruiting

NCT05576129Not Applicable

Transcranial Alternating Current Stimulation (tACS) to Improve Motor Skill Acquisition in Stroke Patients

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4